trihexyphenidyl has been researched along with Dysarthosis in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirabayashi, S | 1 |
| Kanda, H | 1 |
| Tsuno, T | 1 |
| Akabane, T | 1 |
| Oguchi, K | 1 |
| Yanagisawa, N | 1 |
1 other study available for trihexyphenidyl and Dysarthosis
| Article | Year |
|---|---|
[Effects of high-dosage trihexyphenidyl on symptomatic dystonia in a case of Wilson disease].
Topics: Adolescent; Dysarthria; Dystonia; Hepatolenticular Degeneration; Humans; Male; Trihexyphenidyl | 1985 |